| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 39 | / | 2012 | ||||||||
| Date of issue: | 2012-05-03 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| SPH invitation | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Dear Sirs, In compliance with art. 100k, para. 1 from the POSA, we would like to notify that on 18 May 2012 (Friday) Sopharma AD will conduct a regular Annual Meeting with Investors, which will take place in the Conference center of Sopharma Business Towers. We kindly request that all interested parties notify us not later than May 11, 2012 by e-mail [email protected] or by telephone +3592 8134 319 in order to receive their registration forms. Places is limited. In accordance with the provisions of art. 100 k., para. 1 from the POSA, please make the aforementioned information public. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SPH invitation en.doc | SPH invitation | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2012-05-03 | Ognian Donev | Executive Director | |||
